JCR Pharmaceuticals Co., Ltd.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-33
RECRUITING1
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO67%
Delay Index: of 6 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +43.0 months). See all sponsors →
Open JCR Pharmaceuticals Co., Ltd. on the live radar map →| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| JR-141 NCT03708965 |
P2 | Active, not recruiting | Mucopolysaccharidosis II | 19 | 2026-12-31 (+67 mo) |
| JR-141 NCT04573023 |
P3 | Active, not recruiting | Mucopolysaccharidosis II | 86 | 2027-10-31 (+43 mo) |
| JR-141 NCT05594992 |
P3 | Enrolling by invitation | Mucopolysaccharidosis II | 80 | 2028-02-28 |
| JR-446 NCT07640984 |
P1/2 | Recruiting | Mucopolysaccharidosis IIIB | 12 | 2028-06-30 |
| JR-441 NCT06095388 |
P1/2 | Active, not recruiting | Mucopolysaccharidosis III-A | 15 | 2029-10-31 |
| JR-141 NCT04348136 |
P2/3 | Active, not recruiting | Mucopolysaccharidosis II | 27 | 2030-03-31 (+105 mo) |
| JR-446 NCT06488924 |
P1/2 | Active, not recruiting | Mucopolysaccharidosis III-B | 10 | 2030-04-30 (+37 mo) |